UCSF

ZINC03826253

Substance Information

In ZINC since Heavy atoms Benign functionality
November 7th, 2005 29 Yes

Other Names:

(1'S,6'S)-1-Cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

(4aS-cis)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(octahydro-6H-pyrrolol(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid, monohydrochloride; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-o

oxacin

1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid

1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid; LS-141510; Moxifloxacin; Moxifloxacin [INN:BAN]

1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4

1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid HCl

1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride

1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride hydrate

1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylicacid

1-cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-octahydropyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride

1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4 -oxo-quinoline-3-carboxylic acid

151096-09-2

151096-09-2; Avelox IV (TN); D08237; Moxifloxacin (INN)

186826-86-8

186826-86-8; Avelox (TN); D00874; MFLX; Moxifloxacin hydrochloride (JAN/USAN); Vigamox (TN)

186826-86-8; C08054; Moxifloxacin hydrochloride

192927-63-2

3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-

7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid

8-Fluoro-6-methoxyMoxifloxacin

AC1L49EP

Actira

Actira (*Hydrochloride*)

Avalox

Avelox

Avelox (*Hydrochloride*)

Avelox I.V.

Avelox, Avalox

BAY 12-8039

BAY 12-8039 (*Hydrochloride*)

BAY-12-8039

BAY-12-8039; BAY-128039

BAY-128039; BAY-12-8039

CCRIS 8690

CHEBI:7007

CHEMBL32

CID152946

CPD000469185; MOXIFLOXACIN HCl

CPD000469185; MOXIFLOXACIN HCl; SAM001246654

CPD000469185; Moxifloxacin hydrochloride; SAM001246654

DAP000158

DB00218

I06-1961

INN)

INN); Moxifloxacin HCl (FDA

Izilox

LS-141510

LS-190104

MFCD00949117

MFCD04117996

MFX

Moxeza

Moxifloxacin (BAN

Moxifloxacin (Hydrochloride)

moxifloxacin cation; moxifloxacin(1+); moxifloxacinium; moxifloxacinium cation

MOXIFLOXACIN HCL

Moxifloxacin hydrochloride

Moxifloxacin Hydrochloride (FDA

Moxifloxacin [INN:BAN]

Moxifloxacin(HCl form)

Moxifloxacin, HCl

Moxifloxacin,HydrochlorideMonohydrate

Moxifloxacine hydrochloride

MOXIFLOXACINHYDROCHLORIDE

moxifloxacinium(1+)

Moxivig

MXF

MXFX

NA

Not available

Octegra

Proflox

UNII-U188XYD42P

USAN)

USAN); Moxifloxacin (BAN

Vegamox

Vigamox

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 0.39 10.22 -94.83 2 7 0 91 401.438 4
Mid Mid (pH 6-8) -2.35 8.21 -79.31 3 7 1 94 402.446 3

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 1.68e-01 g/l DrugBank-approved
BP 636° Matrix Scientific
Purity 99% Matrix Scientific
Indications antibiotic KeyOrganics Bioactives
PUBCHEM_PATENT_ID EP0971691A2; US5607942; WO1998036732A2; WO1999015172A1; WO1999064037A1; WO2000018386A2; WO2000018388A2; WO2000018404A1; WO2000025765A2; WO2000027398A1; WO2000032196A2; WO2000050007A1; WO2000068229A2; WO2000071541A1 IBM Patent Data
UniProt Database Links FLQE1_MYCTU; FLQE2_MYCTU; FLQE3_MYCTU; NORB_STAA8 ChEBI
Warnings IRRITANT Matrix Scientific
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP06644m; 1 hydrogen chloride NIH Clinical Collection via PubChem
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP06644m; SALT: 1 hydrogen chloride NIH Clinical Collection via PubChem
Target Topoisomerase Selleck Chemicals
PUBCHEM_PATENT_ID US5480879 IBM Patent Data

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )